ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

DeVita Considers Laetrile Tests

June 3, 1977

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

House panel investigating NIH handling of tissue specimens.

June 24, 2005

Roswell Park Wins $2.8 Million Grant

July 31, 2009

FDA’s Jane Henney

February 11, 1994